Homocysteine as a risk factor for hypertension: A 2-year follow-up study

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wang, Yixuan ^a   Chen, Shuohua ^b   Yao, Tao ^c   Li, DongQing ^c   Wang, YanXiu ^c   Li, YuQing ^c   Wu, ShouLing ^c   Cai, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Health Department of Kailuan Group   (China)

^c HEBEI UNITED UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL EVALUATION; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84907891457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108223     Document Type: Article

References (33)

1. Krauss T, Schunkert H, European Society of Cardiology, Leitlinien der Deutschen Hochdruckliga (2009) Management of hypertension (ESC guideline 2007/DHL guideline 2008). Herz 34: 15-20.
2. Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG (2006) The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. J Nutr 136: 1731S-1740S.
3. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, et al. (1997) Plasma homocysteine as a risk factor for vascular disease. The european concerted action project. JAMA 277: 1775-1781.
4. Adachi H, Matsuoka H, Usui M, Imaizumi T (2000) homocysteine and hypertension. Nihon Rinsho 58 Suppl 2: 415-417.
5. Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C (1997) High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 96: 1745-1749.
6. Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49: 31-62.
7. Selhub J, Miller JW (1992) The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by s-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55: 131-138.
8. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050.
9. Ovechkin AV, Tyagi N, Sen U, Lominadze D, Steed MM, et al. (2006) 3-deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am J Physiol Lung Cell Mol Physiol 291: L905-911.
10. Sen U, Tyagi SC (2010) Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role? PPAR Res 2010: 806538.
11. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, et al. (2007) High prevalence of hyperhomocysteinemia in chinese adults is associated with low folate, vitamin b-12, and vitamin b-6 status. J Nutrition 137: 407-413.
12. Lim U, Cassano PA (2002) Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 156: 1105-1113.
13. Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, et al. (2007) Uremic hyperhomocysteinemia: A randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial Int 11: 210-216.
14. Mcmahon JA, Skeaff CM, Williams SM, Green TJ (2007) Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 137: 1183-1187.
15. Hankey GJ, Eikelboom JW, Ho WK, Van Bockxmeer FM (2004) Clinical usefulness of plasma homocysteine in vascular disease. Med J Aust 181: 314-318.
16. Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, et al. (2014) Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med 25: 538-44.
17. Xiao W, Bai Y, Ye P, Luo L, Liu D, et al. (2014) Plasma homocysteine is associated with aortic arterial stiffness but not wave reflection in Chinese hypertensive subjects. PLoS One 9: e85938.
18. Sundstrom J, Sullivan L, D'agostino RB, Jacques PF, Selhub J, et al. (2003) Plasma homocysteine, hypertension incidence, and blood pressure tracking: The framingham heart study. Hypertension 42: 1100-1105.
19. Bowman TS, Gaziano JM, Stampfer MJ, Sesso HD (2006) Homocysteine and risk of developing hypertension in men. J Hum Hypertens 20: 631-634.
20. Forman JP, Choi H, Curhan GE (2009) Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 169: 155-162.
21. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, et al. (2007) Multiple biomarkers and the risk of incident hypertension. Hypertension 49: 432-438.
22. Fowdar JY, Lason MV, Szvetko AL, Lea RA, Griffiths LR (2012) Investigation of homocysteine-pathway-related variants in essential hypertension. Int J Hypertens 2012: 190923.
23. Xun P, Liu K, Loria CM, Bujnowski D, Shikany JM, et al. (2012) Folate intake and incidence of hypertension among american young adults: A 20-y follow-up study. Am J Clin Nutr 95: 1023-1030.
24. Poduri A, Kaur J, Thakur JS, Kumari S, Jain S, et al. (2008) Effect of ace inhibitors and beta-blockers on homocysteine levels in essential hypertension. J Hum Hypertens 22: 289-294.
25. Fan FF, Huo Y, Wang X, Xu X, Wang BY, et al. (2010) Effect of enalapril on plasma homocysteine levels in patients with essential hypertension. J Zhejiang Univ Sci 11: 583-591.
26. Atar I, Korkmaz ME, Demircan S, Atar IA, Bozbas H, et al. (2005) Beta blocker effects on plasma homocysteine levels in patients with hypertension. Atherosclerosis 181: 399-402.
27. Tyagi N, Moshal KS, Lominadze D, Ovechkin AV, Tyagi SC (2005) Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip goldblatt hypertension mouse model. Can J Physiol Pharmacol 83: 583-594.
28. Bogdanski P, Miller-Kasprzak E, Pupek-Musialik D, Jablecka A, Lacinski M, et al. (2012) Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension. Clin Chem Lab Med 50: 1107-1113.
29. Vyssoulis G, Karpanou E, Kyvelou SM, Adamopoulos D, Gialernios T, et al. (2012) Associations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controls. J Hum Hypertens 24: 183-189.
30. Mizrahi EH, Noy S, Sela BA, Fleissig Y, Arad M, et al. (2003) Further evidence of interrelation between homocysteine and hypertension in stroke patients: A cross-sectional study. Isr Med Assoc J 5: 791-794.
31. Firbank MJ, Narayan SK, Saxby BK, Ford GA, O'brien JT (2010) Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension. Int Psychogeriatr 22: 804-811.
32. Gokkusu C, Ozbek Z, Tata G (2012) Hormone replacement therapy: Relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women. Arch Gynecol Obstet 285: 733-739.
33. Yu HG, Ku SY, Choi J, Kim H, Suh CS, et al. (2010) Sex steroid and tropic hormone levels may be associated with postoperative prognosis of vitrectomy in korean postmenopausal women: A pilot study. Menopause 17: 161-165.